×
Ocugen Net Current Debt 2013-2025 | OCGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Ocugen net current debt from 2013 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
View More
Ocugen Net Current Debt 2013-2025 | OCGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Ocugen net current debt from 2013 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$218.6B
Amgen (AMGN)
$164.4B
Gilead Sciences (GILD)
$137B
Vertex Pharmaceuticals (VRTX)
$120.7B
Bristol Myers Squibb (BMY)
$97.7B
CSL (CSLLY)
$84.2B
GSK (GSK)
$75.8B
Regeneron Pharmaceuticals (REGN)
$60.6B
Alnylam Pharmaceuticals (ALNY)
$42.4B
Argenex SE (ARGX)
$35B
BioNTech SE (BNTX)
$26.8B
Royalty Pharma (RPRX)
$20.3B
Insmed (INSM)
$19.5B
Biogen (BIIB)
$18.7B
Illumina (ILMN)
$16.2B
Genmab (GMAB)
$14B
Genmab (GNMSF)
$13.8B
Incyte (INCY)
$13.3B
Moderna (MRNA)
$12.7B
Exelixis (EXEL)
$12.1B
BioMarin Pharmaceutical (BMRN)
$11.4B
QIAGEN (QGEN)
$11B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10.1B
Exact Sciences (EXAS)
$9.4B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.3B
Bio-Techne Corp (TECH)
$8.3B
Legend Biotech (LEGN)
$8.1B
Roivant Sciences (ROIV)
$7.8B